Resistance Heterogeneity and Small Airway Asthma Phenotype
To the Editor:
We read with interest the elegant modeling data of Foy and colleagues (1) , who reported a 40% narrowing of small airways was associated with clinically relevant alterations in asthma control and quality of life. Such effects were commensurate with observed responses to biologics on the frequency-dependent heterogeneity of the resistance component of respiratory impedance measured by impulse oscillometry (IOS), where the mean pooled effect on resistance at 5 Hz (R5) 2 resistance at 20 Hz (R20) was 20.04 (95% confidence interval [CI], 20.03 to 20.05) (kPa/L) $ s. To further put these changes into clinical context, we previously measured IOS in response to propranolol-induced bronchoconstriction in patients with asthma where there was a 0.05 (kPa/L) $ s increase in R5 2 R20 corresponding to a 104.1% (95% CI, 22.6 to 185.6%) change, along with a subsequent bronchodilator response to salbutamol of 20.17 (kPa/L) $ s and 2115.6% (95% CI, 255.6% to 2175.7%), respectively (2) . Moreover, in a health informatics evaluation of 302 patients with asthma, there was a 45% increased risk for worse control in relation to oral corticosteroid use, and 47% in relation to inhaled albuterol use measured during a 2-year period when comparing cohorts of patients with asthma, using a cutoff value for R5 2 R20 of less than or greater than 0.07 (kPa/L) $ s (3).
Hence, the small airway asthma phenotype reflected by abnormal R5 2 R20 is associated with poorer control. We believe the findings of Foy and colleagues (1) are important in further validating the use of IOS in determining effects of treatments on small airways of patients with asthma. n
